+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

D0870 a new triazole antifungal agent activity against candida albicans in experimental vaginal and systemic infections in mice



D0870 a new triazole antifungal agent activity against candida albicans in experimental vaginal and systemic infections in mice



Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 32: 285




(PDF emailed within 1 workday: $29.90)

Accession: 030789735

Download citation: RISBibTeXText


Related references

Comparison of D0870, a new triazole antifungal agent, to fluconazole for inhibition of Candida albicans cytochrome P-450 by using in vitro assays. Antimicrobial Agents and ChemoTherapy 40(6): 1382-1386, 1996

Modification of the phagocytic and intracellular killing capacity of human neutrophils against Candida albicans by D0870 a new triazole antifungal agent. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 33(0): 188, 1993

In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus. Antimicrobial Agents and ChemoTherapy 38(11): 2553-2556, 1994

In vitro studies of a new antifungal triazole, D0870, against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts. Antimicrobial Agents and ChemoTherapy 37(10): 2126-2131, 1993

In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans. Medical Mycology 43(3): 227-233, 2005

Antifungal activity of a new triazole, D0870, compared with four other antifungal agents tested against clinical isolates of Candida and Torulopsis glabrata. Diagnostic Microbiology & Infectious Disease. : 75-80, 1994

Excellent therapeutic efficacy of D0870, a triazole antifungal agent, against local infections and its mechanism of action. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 33(0): 188, 1993

Colorimetric MTT assessment of antifungal activity of D0870 against fluconazole-resistant Candida albicans. Mycoses 41(11-12): 477-480, 1999

In-vitro activity of D0870, a new triazole antifungal drug, in comparison with fluconazole and itraconazole against Aspergillus fumigatus and Candida krusei. Journal of Antimicrobial ChemoTherapy 39(6): 731-736, 1997

Activities of D0870, a novel triazole, against Candida lusitaniae and Trichosporon beigelii in experimental murine infections. Antimicrobial Agents and ChemoTherapy 39(2): 571-573, 1995

D0870, a new triazole agent Activity against experimental cryptococcal meningitis. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 34(0): 255, 1994

Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes. Antimicrobial Agents and ChemoTherapy 27(5): 832-835, 1985

In vivo antifungal activity of SS750, a new triazole agent, against systemic and pulmonary candidosis in mice. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 40: 199, 2000

In vitro and in vivo antifungal activities of D0870, a new triazole agent. Antimicrobial Agents and ChemoTherapy 37(11): 2412-2417, 1993